BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 20478348)

  • 1. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.
    Bidwell GL; Raucher D
    Adv Drug Deliv Rev; 2010 Dec; 62(15):1486-96. PubMed ID: 20478348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
    Massodi I; Bidwell GL; Raucher D
    J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal Penetrating Elastin-Like Polypeptide Carriers.
    George EM; Mahdi F; Logue OC; Robinson GG; Bidwell GL
    J Ocul Pharmacol Ther; 2016 Apr; 32(3):163-71. PubMed ID: 26672799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.
    Walker L; Perkins E; Kratz F; Raucher D
    Int J Pharm; 2012 Oct; 436(1-2):825-32. PubMed ID: 22850291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study.
    Ryu JS; Kratz F; Raucher D
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy.
    Bidwell GL; Raucher D
    Mol Cancer Ther; 2005 Jul; 4(7):1076-85. PubMed ID: 16020665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide.
    Raucher D; Massodi I; Bidwell GL
    Expert Opin Drug Deliv; 2008 Mar; 5(3):353-69. PubMed ID: 18318656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elastin-like polypeptides: the influence of its molecular weight on local hyperthermia-induced tumor accumulation.
    Ryu JS; Raucher D
    Eur J Pharm Biopharm; 2014 Oct; 88(2):382-9. PubMed ID: 24866938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to solid tumors by elastin-like polypeptides.
    McDaniel JR; Callahan DJ; Chilkoti A
    Adv Drug Deliv Rev; 2010 Dec; 62(15):1456-67. PubMed ID: 20546809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
    Dragojevic S; Mackey R; Raucher D
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.
    Ryu JS; Raucher D
    Expert Opin Drug Deliv; 2015 Apr; 12(4):653-67. PubMed ID: 25350837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia.
    Meyer DE; Kong GA; Dewhirst MW; Zalutsky MR; Chilkoti A
    Cancer Res; 2001 Feb; 61(4):1548-54. PubMed ID: 11245464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo.
    Moktan S; Perkins E; Kratz F; Raucher D
    Mol Cancer Ther; 2012 Jul; 11(7):1547-56. PubMed ID: 22532601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery.
    Dragojevic S; Turner L; Raucher D
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells.
    Opačak-Bernardi T; Ryu JS; Raucher D
    J Drug Target; 2017 Jul; 25(6):523-531. PubMed ID: 28140690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.
    Massodi I; Moktan S; Rawat A; Bidwell GL; Raucher D
    Int J Cancer; 2010 Jan; 126(2):533-44. PubMed ID: 19588502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.
    Bidwell GL; Davis AN; Raucher D
    J Control Release; 2009 Apr; 135(1):2-10. PubMed ID: 19095020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide.
    Kuna M; Mahdi F; Chade AR; Bidwell GL
    Sci Rep; 2018 May; 8(1):7923. PubMed ID: 29784932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.
    Ryu JS; Kuna M; Raucher D
    Ther Deliv; 2014 Apr; 5(4):429-45. PubMed ID: 24856169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.